Literature DB >> 7562532

Mu-opioid receptor regulation during opioid tolerance and supersensitivity in rat central nervous system.

A Diaz1, F Ruiz, J Flórez, M A Hurlé, A Pazos.   

Abstract

We have analyzed by radiometric procedures in rat central nervous system the changes in the properties of mu-opioid receptors associated with tolerance and supersensitivity to the opioid agonist sufentanil. This study has used [3H]-[D-Ala2,MePhe4,Gly- (ol)5(2)]-enkephalin, a highly selective ligand, to label mu-opioid receptors in both membranes and tissue sections. The induction of opioid tolerance by chronic infusion for 7 days of high doses of sufentanil, a high efficacy agonist, produced mu-opioid receptor down-regulation, with a significant decrease in their density in both cortical (-67%) and spinal cord membranes (-55%) and no changes in the affinity constant. Autoradiographic studies showed an overall decrease of[3H]-Ala2,MePhe4,Gly-(ol)5(2)]-enkephalin binding in the somatosensory cortex (around -30%). When the dihydropyridine-Ca++ channel antagonist nimodipine was administered alone for 7 days, no significant changes in the density or affinity constant of mu-opioid receptors were observed. However, the chronic and simultaneous administration of nimodipine and sufentanil (7 days), induced a pronounced modification on the density of mu-opioid receptors of the rat central nervous system and blocked the down-regulation observed in sufentanil-treated (tolerant) rats. These neurochemical findings may account for the functional interaction we have observed previously in the analgesic studies between nimodipine and sufentanil. Our data strongly suggest a functional role of L-type Ca++ channels in the mediation of opioid tolerance and super-sensitivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562532

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Involvement of the cyclic AMP system in the switch from tolerance into supersensitivity to the antinociceptive effect of the opioid sufentanil.

Authors:  M A Hurlé; I Goirigolzarri; E M Valdizán
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  Sensitivity to the effects of opioids in rats with free access to exercise wheels: mu-opioid tolerance and physical dependence.

Authors:  Mark A Smith; David L Yancey
Journal:  Psychopharmacology (Berl)       Date:  2003-04-23       Impact factor: 4.530

4.  Voluntary and forced exercises prevent the development of tolerance to analgesic effects of morphine in rats.

Authors:  Monireh Shokraviyan; Hossein Miladi-Gorji; Gholam Hassan Vaezi
Journal:  Iran J Basic Med Sci       Date:  2014       Impact factor: 2.699

Review 5.  The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.

Authors:  Gerald W Zamponi; Joerg Striessnig; Alexandra Koschak; Annette C Dolphin
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

6.  Population pharmacokinetics and pharmacokinetic-pharmacodynamic relationships of methadone in a sample of Iranian (mazandarani) opiate users undergoing methadone maintenance treatment.

Authors:  Mohammad-Reza Shiran; Rasa Hosseinzadeh; Abolhassan Hamidikenari; Mehran Zarghami; Nargess Lamsehchi; Mohammad-Reza Rafati
Journal:  Iran J Psychiatry Behav Sci       Date:  2011

Review 7.  Opioid Receptor Regulation of Neuronal Voltage-Gated Calcium Channels.

Authors:  Norbert Weiss; Gerald W Zamponi
Journal:  Cell Mol Neurobiol       Date:  2020-06-08       Impact factor: 5.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.